p c jun n terminal kinase (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
97
Structured Review
Cell Signaling Technology Inc
p c jun n terminal kinase
P C Jun N Terminal Kinase, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 3614 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+c+jun+n+terminal+kinase/Phospho-SAPK%2FJNK+(Thr183%2FTyr185)+Rabbit+mAb/pm41760308-88-111-116
Average 97 stars, based on 3614 article reviews
P C Jun N Terminal Kinase, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 3614 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+c+jun+n+terminal+kinase/Phospho-SAPK%2FJNK+(Thr183%2FTyr185)+Rabbit+mAb/pm41760308-88-111-116
Average 97 stars, based on 3614 article reviews
p c jun n terminal kinase - by Bioz Stars,
2026-10
97/100 stars
Images
Related Articles
Incubation:Article Title: Luteolin sensitizes human liver cancer cells to TRAIL‑induced apoptosis via autophagy and JNK‑mediated death receptor 5 upregulation. Article Snippet: .. The cells were then incubated in a blocking solution followed by overnight incubation at 4°C with anti‐p62 (cat. no. 5114; 1:1,000) and Article Title: SBC (Sanhuang Xiexin Tang combined with Baihu Tang plus Cangzhu) alleviates NAFLD by enhancing mitochondrial biogenesis and ameliorating inflammation in obese patients and mice Article Snippet: Department of Endocrinology & Metabolism, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510000, China; Guangdong Provincial Key Laboratory of Diabetology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510000, China; Guangzhou Municipal Key Laboratory of Mechanistic and Translational Obesity Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510000, China; Medical Center for Comprehensive Weight Control, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510000, China; Department of Traditional Chinese Medicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510000, China; Department of Cardiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510000, China; School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518000, China; Guangdong e-fong Pharmaceutical Co., Ltd., Foshan 528000, China; Faculty of Health Sciences, University of Macau, Macau 999078, China; Foshan Fourth People’s Hospital, Foshan 528000, China Blocking Assay:Article Title: Luteolin sensitizes human liver cancer cells to TRAIL‑induced apoptosis via autophagy and JNK‑mediated death receptor 5 upregulation. Article Snippet: .. The cells were then incubated in a blocking solution followed by overnight incubation at 4°C with anti‐p62 (cat. no. 5114; 1:1,000) and Article Title: SBC (Sanhuang Xiexin Tang combined with Baihu Tang plus Cangzhu) alleviates NAFLD by enhancing mitochondrial biogenesis and ameliorating inflammation in obese patients and mice Article Snippet: Department of Endocrinology & Metabolism, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510000, China; Guangdong Provincial Key Laboratory of Diabetology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510000, China; Guangzhou Municipal Key Laboratory of Mechanistic and Translational Obesity Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510000, China; Medical Center for Comprehensive Weight Control, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510000, China; Department of Traditional Chinese Medicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510000, China; Department of Cardiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510000, China; School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518000, China; Guangdong e-fong Pharmaceutical Co., Ltd., Foshan 528000, China; Faculty of Health Sciences, University of Macau, Macau 999078, China; Foshan Fourth People’s Hospital, Foshan 528000, China other:Article Title: Physalin A Suppresses Human Oral Squamous Carcinoma Cell Migration and Invasion Through Inhibiting Grb2/Ras and MMP/uPA Signaling Pathways. Article Snippet: The quantified proteins were electrophoretically separated by 8-12% SDSPAGE gel (based on different KDa), and were transferred to polyvinylidene difluoride (PVDF; Cat. No. IPVH00010; Merck Millipore, Burlington, MA, USA) membranes, which were blocked with 5% albumin. Article Title: Physalin A Suppresses Human Oral Squamous Carcinoma Cell Migration and Invasion Through Inhibiting Grb2/Ras and MMP/uPA Signaling Pathways Article Snippet: The membranes were then stained using primary antibodies [anti- plasminogen activator inhibitor 1 (PAI-1; sc-5297; Santa Cruz Biotechnology), -uPA (sc-59727; Santa Cruz Biotechnology), -E-cad (sc-374067; Santa Cruz Biotechnology), -α-tubulin (α-tub; sc-8035; Santa Cruz Biotechnology), -MMP-1 (sc-21731; Santa Cruz Biotechnology), -MMP-2 (sc-13595; Santa Cruz Biotechnology), -MMP-3 (sc-21732; Santa Cruz Biotechnology), -MMP-9 (sc-393859; Santa Cruz Biotechnology), -tissue inhibitor of metalloprotease (TIMP-1; sc-365905; Santa Cruz Biotechnology), -TIMP-2 (sc-21735; Santa Cruz Biotechnology), -p-IKK (p-IKK; sc-293135; Santa Cruz Biotechnology), -IKK (sc-8032; Santa Cruz Biotechnology), -p-IκB (sc-8404; Santa Cruz Biotechnology), -IκB (sc-1643; Santa Cruz Biotechnology), -NF-κB p65 (sc-8008; Santa Cruz Biotechnology), -NF-κB p50 (sc-8414; Santa Cruz Biotechnology), -p-ERK (9911; Cell Signaling Technology), -ERK (9911; Cell Signaling Technology), -p-c-Jun N-terminal kinase (-p-JNK; 4668; Cell Signaling Technology), -JNK (9252; Cell Signaling Technology), -p-p38 (9211; Cell Signaling Technology), -p38 (9212; Cell Signaling Technology), -p-c-Jun (3270; Cell Signaling Technology), -c-Jun (9165; Cell Signaling Technology), -Grb2 (3972; Cell Signaling Technology), -Ras (3965; Cell Signaling Technology), -p-PI3K (4228; Cell Signaling Technology), -PI3K (4292; Cell Signaling Technology), -p-Akt (9271; Cell Signaling Technology), -Akt (9272; Cell Signaling Technology), -PCNA (sc-56; Santa Cruz Biotechnology) and -β-actin (sc-47778; Santa Cruz Biotechnology)] in 4°C overnight. Marker:Article Title: Ginsenoside protopanaxadiol protects adult retinal pigment epithelial-19 cells from chloroquine by modulating autophagy and apoptosis Article Snippet: Asiatic acid (#A2612), bafilomycin A1 (BA1) (#B1793), compound C (#P5499), CQ (#C6628), ammonium chloride (NH 4 Cl, #A9434), PPD (#P0031), rapamycin (Rap, #553210), and staurosporine (#S5921) were acquired from Sigma-Aldrich (St. Louis, MO, USA). .. Antibodies against the autophagy marker light chain 3 (LC3) A/B (#12741), p62 (#8025), mechanistic target of Rap (mTOR) (#2983), phosphorylated (p)-mTOR (#5536), Bcl-xL (#2764), Bcl-2 (#15071), p38 mitogen-activated protein kinase (MAPK, #8690), p-p38 MAPK (#4511), Pyrolysis Gas Chromatography:Article Title: SBC (Sanhuang Xiexin Tang combined with Baihu Tang plus Cangzhu) alleviates NAFLD by enhancing mitochondrial biogenesis and ameliorating inflammation in obese patients and mice Article Snippet: Department of Endocrinology & Metabolism, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510000, China; Guangdong Provincial Key Laboratory of Diabetology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510000, China; Guangzhou Municipal Key Laboratory of Mechanistic and Translational Obesity Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510000, China; Medical Center for Comprehensive Weight Control, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510000, China; Department of Traditional Chinese Medicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510000, China; Department of Cardiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510000, China; School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518000, China; Guangdong e-fong Pharmaceutical Co., Ltd., Foshan 528000, China; Faculty of Health Sciences, University of Macau, Macau 999078, China; Foshan Fourth People’s Hospital, Foshan 528000, China |